Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
8.06
0.00
(0.00%)
At close: March 4 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
26,199,409
26,199,409
26,026,164
26,861,356
23,647,224
Cost of Revenue
4,989,877
4,989,877
4,487,616
5,332,095
5,182,320
Gross Profit
21,209,532
21,209,532
21,538,548
21,529,261
18,464,904
Operating Expense
15,423,818
15,423,818
16,058,744
17,175,600
14,160,755
Operating Income
5,785,714
5,785,714
5,479,804
4,353,661
4,304,149
Net Non Operating Interest Income Expense
-308,562
-308,562
-233,586
-146,560
-129,365
Pretax Income
5,409,906
5,409,906
5,214,869
18,572,673
5,013,044
Tax Provision
797,267
797,267
696,716
1,957,880
672,377
Net Income Common Stockholders
2,543,134
2,543,134
2,311,200
14,125,901
2,771,086
Average Dilution Earnings
211,195
--
-232,370
-482,511
--
Diluted NI Available to Com Stockholders
2,543,134
2,543,134
2,311,200
14,125,901
2,771,086
Basic EPS
2.52
2.52
2.72
15.57
2.95
Diluted EPS
2.52
2.52
2.43
14.65
2.95
Basic Average Shares
926,453.25
926,453.25
931,112.45
938,432.49
940,014.21
Diluted Average Shares
928,754.02
928,754.02
950,860.10
964,147.75
940,014.21
Rent Expense Supplemental
139,878
139,878
116,657
--
--
Total Expenses
20,413,695
20,413,695
20,546,360
22,507,695
19,343,075
Net Income from Continuing & Discontinued Operation
2,331,939
2,331,939
2,543,570
14,608,412
2,771,086
Normalized Income
1,887,083.86
1,887,083.86
2,403,020.89
14,860,393.60
2,383,158.64
Interest Income
186,675
186,675
195,908
162,057
194,003
Interest Expense
495,237
495,237
429,494
308,617
323,368
Net Interest Income
-308,562
-308,562
-233,586
-146,560
-129,365
EBIT
5,905,143
5,905,143
5,644,363
18,881,290
5,336,412
EBITDA
6,979,427
6,979,427
6,691,347
19,873,846
6,991,248
Reconciled Cost of Revenue
4,989,877
4,989,877
4,487,616
5,332,095
5,182,320
Reconciled Depreciation
1,074,284
1,074,284
1,046,984
992,556
1,654,836
Net Income from Continuing Operation Net Minority Interest
1,847,180
1,847,180
2,059,105
14,608,412
2,771,086
Total Unusual Items Excluding Goodwill
-46,801
-46,801
-396,949
-281,675
448,018
Total Unusual Items
-46,801
-46,801
-396,949
-281,675
448,018
Normalized EBITDA
7,026,228
7,026,228
7,088,296
20,155,521
6,543,230
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-6,897.14
-6,897.14
-53,033.11
-29,693.40
60,090.64
12/31/2020 - 9/5/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MTVA MetaVia Inc.
1.5200
+1.33%
ZIVO ZIVO Bioscience, Inc.
19.80
+1.54%
PHVS Pharvaris N.V.
14.99
-2.98%
IKNA Ikena Oncology, Inc.
1.3500
0.00%
RLYB Rallybio Corporation
0.6960
-3.28%
APRE Aprea Therapeutics, Inc.
2.6400
+3.53%
SPRB Spruce Biosciences, Inc.
0.3592
+0.53%
VALN Valneva SE
7.14
+4.93%
SPRO Spero Therapeutics, Inc.
0.7702
+0.09%
PASG Passage Bio, Inc.
0.4702
+10.53%